Abbott Laboratories (ABT)
USD 111.93
(-1.2%)
USD 111.93
(-1.2%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 40.1 Billion USD | -8.12% |
| 2022 | 43.65 Billion USD | 1.34% |
| 2021 | 43.07 Billion USD | 24.47% |
| 2020 | 34.6 Billion USD | 8.48% |
| 2019 | 31.9 Billion USD | 4.34% |
| 2018 | 30.57 Billion USD | 11.64% |
| 2017 | 27.39 Billion USD | 31.35% |
| 2016 | 20.85 Billion USD | 2.2% |
| 2015 | 20.4 Billion USD | 0.78% |
| 2014 | 20.24 Billion USD | -7.33% |
| 2013 | 21.84 Billion USD | -45.21% |
| 2012 | 39.87 Billion USD | 2.63% |
| 2011 | 38.85 Billion USD | 10.48% |
| 2010 | 35.16 Billion USD | 14.31% |
| 2009 | 30.76 Billion USD | 4.19% |
| 2008 | 29.52 Billion USD | 13.94% |
| 2007 | 25.91 Billion USD | 15.3% |
| 2006 | 22.47 Billion USD | 0.62% |
| 2005 | 22.33 Billion USD | 13.51% |
| 2004 | 19.68 Billion USD | -0.0% |
| 2003 | 19.68 Billion USD | 11.29% |
| 2002 | 17.68 Billion USD | 8.59% |
| 2001 | 16.28 Billion USD | 18.47% |
| 2000 | 13.74 Billion USD | 4.31% |
| 1999 | 13.17 Billion USD | 5.61% |
| 1998 | 12.47 Billion USD | 5.0% |
| 1997 | 11.88 Billion USD | 7.9% |
| 1996 | 11.01 Billion USD | 10.0% |
| 1995 | 10.01 Billion USD | 9.35% |
| 1994 | 9.15 Billion USD | 8.9% |
| 1993 | 8.4 Billion USD | 7.08% |
| 1992 | 7.85 Billion USD | 14.18% |
| 1991 | 6.87 Billion USD | 11.66% |
| 1990 | 6.15 Billion USD | 14.48% |
| 1989 | 5.37 Billion USD | 8.97% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 10.37 Billion USD | 4.14% |
| 2024 Q1 | 9.96 Billion USD | -2.7% |
| 2024 Q3 | 10.63 Billion USD | 2.49% |
| 2023 Q2 | 9.97 Billion USD | 2.37% |
| 2023 Q4 | 10.24 Billion USD | 0.97% |
| 2023 Q3 | 10.14 Billion USD | 1.65% |
| 2023 FY | 40.1 Billion USD | -8.12% |
| 2023 Q1 | 9.74 Billion USD | -3.41% |
| 2022 FY | 43.65 Billion USD | 1.34% |
| 2022 Q1 | 11.89 Billion USD | 3.72% |
| 2022 Q2 | 11.25 Billion USD | -5.36% |
| 2022 Q3 | 10.41 Billion USD | -7.52% |
| 2022 Q4 | 10.09 Billion USD | -3.06% |
| 2021 Q4 | 11.46 Billion USD | 4.94% |
| 2021 FY | 43.07 Billion USD | 24.47% |
| 2021 Q2 | 10.22 Billion USD | -2.23% |
| 2021 Q1 | 10.45 Billion USD | -2.29% |
| 2021 Q3 | 10.92 Billion USD | 6.9% |
| 2020 Q3 | 8.85 Billion USD | 20.81% |
| 2020 Q1 | 7.72 Billion USD | -7.07% |
| 2020 FY | 34.6 Billion USD | 8.48% |
| 2020 Q4 | 10.7 Billion USD | 20.87% |
| 2020 Q2 | 7.32 Billion USD | -5.15% |
| 2019 Q2 | 7.97 Billion USD | 5.89% |
| 2019 Q4 | 8.31 Billion USD | 2.95% |
| 2019 FY | 31.9 Billion USD | 4.34% |
| 2019 Q1 | 7.53 Billion USD | -2.96% |
| 2019 Q3 | 8.07 Billion USD | 1.22% |
| 2018 FY | 30.57 Billion USD | 11.64% |
| 2018 Q1 | 7.39 Billion USD | -2.62% |
| 2018 Q2 | 7.76 Billion USD | 5.1% |
| 2018 Q4 | 7.76 Billion USD | 1.42% |
| 2018 Q3 | 7.65 Billion USD | -1.43% |
| 2017 Q3 | 6.82 Billion USD | 2.89% |
| 2017 Q1 | 6.33 Billion USD | 18.79% |
| 2017 Q2 | 6.63 Billion USD | 4.77% |
| 2017 Q4 | 7.58 Billion USD | 11.13% |
| 2017 FY | 27.39 Billion USD | 31.35% |
| 2016 Q1 | 4.88 Billion USD | -5.84% |
| 2016 FY | 20.85 Billion USD | 2.2% |
| 2016 Q3 | 5.3 Billion USD | -0.58% |
| 2016 Q4 | 5.33 Billion USD | 0.58% |
| 2016 Q2 | 5.33 Billion USD | 9.17% |
| 2015 FY | 20.4 Billion USD | 0.78% |
| 2015 Q4 | 5.18 Billion USD | 0.74% |
| 2015 Q2 | 5.17 Billion USD | 5.57% |
| 2015 Q3 | 5.15 Billion USD | -0.39% |
| 2015 Q1 | 4.89 Billion USD | -8.57% |
| 2014 Q2 | 5.55 Billion USD | 5.85% |
| 2014 FY | 20.24 Billion USD | -7.33% |
| 2014 Q3 | 5.1 Billion USD | -8.05% |
| 2014 Q1 | 5.24 Billion USD | -7.27% |
| 2014 Q4 | 5.35 Billion USD | 4.94% |
| 2013 Q1 | 5.37 Billion USD | -50.37% |
| 2013 FY | 21.84 Billion USD | -45.21% |
| 2013 Q4 | 5.65 Billion USD | 5.33% |
| 2013 Q3 | 5.36 Billion USD | -1.41% |
| 2013 Q2 | 5.44 Billion USD | 1.26% |
| 2012 Q4 | 10.83 Billion USD | 10.89% |
| 2012 FY | 39.87 Billion USD | 2.63% |
| 2012 Q1 | 9.45 Billion USD | -8.87% |
| 2012 Q2 | 9.8 Billion USD | 3.7% |
| 2012 Q3 | 9.77 Billion USD | -0.35% |
| 2011 Q2 | 9.61 Billion USD | 6.36% |
| 2011 Q3 | 9.81 Billion USD | 2.09% |
| 2011 Q4 | 10.37 Billion USD | 5.71% |
| 2011 FY | 38.85 Billion USD | 10.48% |
| 2011 Q1 | 9.04 Billion USD | -9.3% |
| 2010 Q3 | 8.67 Billion USD | -1.71% |
| 2010 FY | 35.16 Billion USD | 14.31% |
| 2010 Q1 | 7.69 Billion USD | -12.42% |
| 2010 Q2 | 8.82 Billion USD | 14.65% |
| 2010 Q4 | 9.96 Billion USD | 14.9% |
| 2009 FY | 30.76 Billion USD | 4.19% |
| 2009 Q3 | 7.76 Billion USD | 3.55% |
| 2009 Q4 | 8.79 Billion USD | 13.26% |
| 2009 Q1 | 6.71 Billion USD | -15.5% |
| 2009 Q2 | 7.49 Billion USD | 11.56% |
| 2008 Q3 | 7.49 Billion USD | 2.51% |
| 2008 FY | 29.52 Billion USD | 13.94% |
| 2008 Q4 | 7.95 Billion USD | 6.04% |
| 2008 Q2 | 7.31 Billion USD | 8.11% |
| 2008 Q1 | 6.76 Billion USD | -6.31% |
| 2007 Q2 | 6.37 Billion USD | 20.42% |
| 2007 Q1 | 5.29 Billion USD | -14.92% |
| 2007 Q4 | 7.22 Billion USD | 13.25% |
| 2007 FY | 25.91 Billion USD | 15.3% |
| 2007 Q3 | 6.37 Billion USD | 0.1% |
| 2006 Q4 | 6.21 Billion USD | 11.56% |
| 2006 Q3 | 5.57 Billion USD | 1.32% |
| 2006 FY | 22.47 Billion USD | 0.62% |
| 2006 Q2 | 5.5 Billion USD | 6.13% |
| 2006 Q1 | 5.18 Billion USD | -14.29% |
| 2005 Q3 | 5.38 Billion USD | -2.53% |
| 2005 Q1 | 5.38 Billion USD | -4.81% |
| 2005 FY | 22.33 Billion USD | 13.51% |
| 2005 Q4 | 6.04 Billion USD | 12.32% |
| 2005 Q2 | 5.52 Billion USD | 2.62% |
| 2004 Q3 | 4.68 Billion USD | -0.45% |
| 2004 Q1 | 5.21 Billion USD | -5.69% |
| 2004 Q2 | 4.7 Billion USD | -9.84% |
| 2004 Q4 | 5.65 Billion USD | 20.78% |
| 2004 FY | 19.68 Billion USD | -0.0% |
| 2003 Q1 | 4.58 Billion USD | -5.35% |
| 2003 Q2 | 4.72 Billion USD | 3.13% |
| 2003 Q3 | 4.84 Billion USD | 2.59% |
| 2003 Q4 | 5.53 Billion USD | 14.13% |
| 2003 FY | 19.68 Billion USD | 11.29% |
| 2002 Q1 | 4.18 Billion USD | -5.75% |
| 2002 Q4 | 4.83 Billion USD | 11.47% |
| 2002 FY | 17.68 Billion USD | 8.59% |
| 2002 Q3 | 4.34 Billion USD | 0.61% |
| 2002 Q2 | 4.31 Billion USD | 3.0% |
| 2001 Q2 | 4.09 Billion USD | 15.15% |
| 2001 Q3 | 4.18 Billion USD | 2.0% |
| 2001 Q4 | 4.44 Billion USD | 6.31% |
| 2001 FY | 16.28 Billion USD | 18.47% |
| 2001 Q1 | 3.55 Billion USD | -3.91% |
| 2000 Q1 | 3.35 Billion USD | -4.6% |
| 2000 Q2 | 3.37 Billion USD | 0.51% |
| 2000 Q3 | 3.31 Billion USD | -1.55% |
| 2000 Q4 | 3.7 Billion USD | 11.66% |
| 2000 FY | 13.74 Billion USD | 4.31% |
| 1999 Q2 | 3.24 Billion USD | -1.69% |
| 1999 Q4 | 3.51 Billion USD | 12.63% |
| 1999 Q1 | 3.29 Billion USD | -0.94% |
| 1999 FY | 13.17 Billion USD | 5.61% |
| 1999 Q3 | 3.12 Billion USD | -3.78% |
| 1998 Q4 | 3.33 Billion USD | 9.71% |
| 1998 FY | 12.47 Billion USD | 5.0% |
| 1998 Q3 | 3.03 Billion USD | -1.01% |
| 1998 Q2 | 3.06 Billion USD | 0.72% |
| 1998 Q1 | 3.04 Billion USD | -2.35% |
| 1997 Q3 | 2.86 Billion USD | -1.21% |
| 1997 Q4 | 3.11 Billion USD | 8.83% |
| 1997 FY | 11.88 Billion USD | 7.9% |
| 1997 Q1 | 2.99 Billion USD | 0.13% |
| 1997 Q2 | 2.9 Billion USD | -3.31% |
| 1996 Q3 | 2.64 Billion USD | -1.97% |
| 1996 FY | 11.01 Billion USD | 10.0% |
| 1996 Q1 | 2.67 Billion USD | 2.91% |
| 1996 Q2 | 2.69 Billion USD | 1.01% |
| 1996 Q4 | 2.99 Billion USD | 13.21% |
| 1995 FY | 10.01 Billion USD | 9.35% |
| 1995 Q4 | 2.59 Billion USD | 8.62% |
| 1995 Q2 | 2.5 Billion USD | -0.95% |
| 1995 Q1 | 2.52 Billion USD | 1.71% |
| 1995 Q3 | 2.39 Billion USD | -4.38% |
| 1994 Q2 | 2.2 Billion USD | -0.51% |
| 1994 Q3 | 2.25 Billion USD | 2.3% |
| 1994 Q4 | 2.48 Billion USD | 10.07% |
| 1994 FY | 9.15 Billion USD | 8.9% |
| 1994 Q1 | 2.21 Billion USD | -0.57% |
| 1993 Q4 | 2.22 Billion USD | 8.14% |
| 1993 FY | 8.4 Billion USD | 7.08% |
| 1993 Q2 | 2.07 Billion USD | 1.38% |
| 1993 Q1 | 2.04 Billion USD | -2.43% |
| 1993 Q3 | 2.06 Billion USD | -0.65% |
| 1992 Q3 | 1.96 Billion USD | 3.15% |
| 1992 Q2 | 1.9 Billion USD | 1.64% |
| 1992 Q4 | 2.09 Billion USD | 6.49% |
| 1992 Q1 | 1.87 Billion USD | -0.45% |
| 1992 FY | 7.85 Billion USD | 14.18% |
| 1991 Q4 | 1.88 Billion USD | 14.07% |
| 1991 FY | 6.87 Billion USD | 11.66% |
| 1991 Q2 | 1.68 Billion USD | 1.78% |
| 1991 Q3 | 1.65 Billion USD | -1.74% |
| 1991 Q1 | 1.65 Billion USD | -3.3% |
| 1990 Q4 | 1.71 Billion USD | 13.49% |
| 1990 FY | 6.15 Billion USD | 14.48% |
| 1990 Q3 | 1.5 Billion USD | 0.23% |
| 1990 Q2 | 1.5 Billion USD | 4.52% |
| 1990 Q1 | 1.43 Billion USD | -1.17% |
| 1989 Q3 | 1.31 Billion USD | -0.62% |
| 1989 Q1 | 1.29 Billion USD | -0.83% |
| 1989 Q4 | 1.45 Billion USD | 11.08% |
| 1989 Q2 | 1.31 Billion USD | 1.78% |
| 1989 FY | 5.37 Billion USD | 8.97% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Allurion Technologies Inc. | 53.46 Million USD | -74916.365% |
| Artivion, Inc. | 354 Million USD | -11230.098% |
| Avanos Medical, Inc. | 673.3 Million USD | -5857.077% |
| Butterfly Network, Inc. | 65.9 Million USD | -60763.429% |
| Butterfly Network, Inc. | 65.9 Million USD | -60763.429% |
| Bio-Rad Laboratories, Inc. | 2.67 Billion USD | -1401.5% |
| Boston Scientific Corporation | 14.24 Billion USD | -181.664% |
| Perspective Therapeutics, Inc. | 7.1 Million USD | -564497.41% |
| CONMED Corporation | 1.24 Billion USD | -3132.11% |
| Edwards Lifesciences Corporation | 6 Billion USD | -567.949% |
| Paragon 28, Inc. | 216.38 Million USD | -18435.6% |
| Glaukos Corporation | 314.71 Million USD | -12644.709% |
| Globus Medical, Inc. | 1.56 Billion USD | -2457.196% |
| Inspire Medical Systems, Inc. | 624.79 Million USD | -6319.505% |
| Integer Holdings Corporation | 1.59 Billion USD | -2412.036% |
| Medtronic plc | 32.36 Billion USD | -23.931% |
| Nevro Corp. | 425.17 Million USD | -9333.55% |
| Owlet, Inc. | 54.01 Million USD | -74162.174% |
| Penumbra, Inc. | 1.05 Billion USD | -3689.151% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 5.54 Billion USD | -622.815% |
| Sonendo, Inc. | 43.86 Million USD | -91337.365% |
| STERIS plc | 5.13 Billion USD | -680.528% |
| Stryker Corporation | 20.49 Billion USD | -95.673% |
| Vapotherm, Inc. | 68.66 Million USD | -58309.18% |
| Zimmer Biomet Holdings, Inc. | 7.39 Billion USD | -442.439% |